Taho Pharmaceuticals Ltd. (TPEX:6467)
159.50
+7.00 (4.59%)
At close: Oct 31, 2025
Taho Pharmaceuticals Revenue
Taho Pharmaceuticals had revenue of 7.78M TWD in the half year ending June 30, 2025, with 296.89% growth. This brings the company's revenue in the last twelve months to 7.78M, down -970.13% year-over-year.
Revenue (ttm)
7.78M
Revenue Growth
-970.13%
P/S Ratio
1,288.23
Revenue / Employee
288.11K
Employees
27
Market Cap
10.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 1.07M | -5.29M | -83.23% |
| Dec 31, 2022 | 6.36M | -6.04M | -48.73% |
| Dec 31, 2017 | 12.40M | -23.61M | -65.57% |
| Dec 31, 2016 | 36.01M | 939.00K | 2.68% |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hon Hai Precision Industry | 7.42T |
| Taiwan Semiconductor Manufacturing Company | 3.63T |
| Quanta Computer | 1.83T |
| Cathay Financial Holding | 1.17T |
| Fubon Financial Holding | 1.01T |
| ASE Technology Holding | 629.74B |
| Wiwynn | 604.83B |
| MediaTek | 583.82B |